Back to results
US 2026/0297104 A1Published application
Oxazole trpml1 agonists and uses thereof
AssigneeLibra Therapeutics, Inc.
InventorsJames Guy BREITENBUCHER, Maria Pia CATALANI, Ali Munaim YOUSIF
Life of this patent
Estimating the term…
Abstract
Described herein are oxazole TRPML1 inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of TRPML 1-mediated disorders or diseases.
Claims44
A compound of Formula (I), or a pharmaceutically acceptable salt, solvate, or stereoisomer thereof:
- wherein:
- R1 is C1-C6alkyl optionally substituted with one or more R;
- R2 is C1-C6alkyl optionally substituted with one or more R;
- or R1 and R2 are taken together to form a heterocycloalkyl or heteroaryl;
- each optionally substituted with one or more R1a;
- each R1a is independently deuterium, halogen, —CN, —NO2, —OH, —ORa, —OC(═O)Ra, —OC(═O)ORb, —OC(═O)NRcRd, —SH, —SRa, —S(═O)Ra, —S(═O)2Ra, —S(═O)2NRcRd, —NRcRd, —NRbC(═O)NRcRd, —NRbC, (═O)Ra, —NRbC, (═O)ORb, —NRbS(═O)Ra, —NRbS(═O)2Ra, —C(═O)Ra, —C(═O)ORb, —C(═O)NRcRd, C1-C6alkyl, C1-C6haloalkyl, C1-C6deuteroalkyl, C2-C6alkenyl, C2-C6alkynyl, C1-C6hydroxyalkyl, C1-C6aminoalkyl, C1-C6heteroalkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, C1-C6alkylene (cycloalkyl), C1-C6alkylene (heterocycloalkyl), C1-C6alkylene (aryl), or C1-C6alkylene (heteroaryl);
- wherein each alkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently and optionally substituted with one or more R;
- or two R1a on the same atom are taken together to form an oxo;
- R3 is C1-C6alkyl, C1-C6haloalkyl, C1-C6deuteroalkyl, C2-C6alkenyl, C2-C6alkynyl, C1-C6hydroxyalkyl, C1-C6aminoalkyl, C1-C6heteroalkyl, cycloalkyl, or heterocycloalkyl, wherein each alkyl, alkenyl, alkynyl, cycloalkyl, and heterocycloalkyl is independently and optionally substituted with one or more R;
- Ring A is aryl or heteroaryl;
- each R4 is independently deuterium, halogen, —CN, —NO2, —OH, —ORa, —OC(═O)Ra, —OC(═O)ORb, —OC(═O)NRcRd, —O-cycloalkyl, —O-heterocycloalkyl, —SH, —SRa, —S(—O)Ra, —S(═O)2Ra, —S(═O)2NRcRd, —NRcRd, —NRDC(═O)NRcRd, —NRbC, (═O)Ra, —NRbC, (═O)ORb, —NRbS(═O)Ra, —NRbS(═O)2Ra, —NRb— cycloalkyl, —NRb-heterocycloalkyl, —C(═O)Ra, —C(═O)ORb, —C(═O)NRcRd, C1-C6alkyl, C1-C6haloalkyl, C1-C6deuteroalkyl, C2-C6alkenyl, C2-C6alkynyl, C1-C6hydroxyalkyl, C1-C6aminoalkyl, C1-C6heteroalkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, C1-C6alkylene (cycloalkyl), C1-C6alkylene (heterocycloalkyl), C1-C6alkylene (aryl), or C1-C6alkylene (heteroaryl);
- wherein each alkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently and optionally substituted with one or more R;
- n is 0-4;
- each Ra is independently C1-C6alkyl, C1-C6haloalkyl, C1-C6deuteroalkyl, C1-C6hydroxyalkyl, C1-C6aminoalkyl, C1-C6heteroalkyl, C2-C6alkenyl, C2-C6alkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, C1-C6alkylene (cycloalkyl), C1-C6alkylene (heterocycloalkyl), C1-C6alkylene (aryl), or C1-C6alkylene (heteroaryl);
- wherein each alkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently and optionally substituted with one or more R;
- each Rb is independently hydrogen, C1-C6alkyl, C1-C6haloalkyl, C1-C6deuteroalkyl, C1-C6hydroxyalkyl, C1-C6aminoalkyl, C1-C6heteroalkyl, C2-C6alkenyl, C2-C6alkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, C1-C6alkylene (cycloalkyl), C1-C6alkylene (heterocycloalkyl), C1-C6alkylene (aryl), or C1-C6alkylene (heteroaryl);
- wherein each alkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently and optionally substituted with one or more R;
- each Rc and Rd are independently hydrogen, C1-C6alkyl, C1-C6haloalkyl, C1-C6deuteroalkyl, C1-C6hydroxyalkyl, C1-C6aminoalkyl, C1-C6heteroalkyl, C2-C6alkenyl, C2-C6alkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, C1-C6alkylene (cycloalkyl), C1-C6alkylene (heterocycloalkyl), C1-C6alkylene (aryl), or C1-C6alkylene (heteroaryl);
- wherein each alkyl, alkylene, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl is independently and optionally substituted with one or more R;
- or Rc and Rd are taken together with the atom to which they are attached to form a heterocycloalkyl optionally substituted with one or more R;
- and
- each R is independently deuterium, halogen, —CN, —OH, —S(═O)C1-C3alkyl, —S(═O)2C1-C6alkyl, —S(═O)2NH2, —S(═O)2NHC1-C3alkyl, —S(═O)2N(C1-C3alkyl)2, —NH2, —NHC1-C3alkyl, —N(C1-C3alkyl)2, —C(═O)C1-C3alkyl, —C(═O) OH, —C(═O)OC1-C3alkyl, —C(═O)NH2, —C(═O)NHC1-C3alkyl, —C(═O)N(C1-C3alkyl)2, C1-C3alkyl, C1-C3alkoxy, C1-C3haloalkyl, C1-C3deuteroalkyl, C1-C3haloalkoxy, C1-Cshydroxyalkyl, C1-C3aminoalkyl, C1-C3heteroalkyl, C3-C3cycloalkyl, or 3- to 6-membered heterocycloalkyl;
- wherein each cycloalkyl and heterocycloalkyl is independently optionally substituted with one or more halogen;
- or two R on the same atom form an oxo.
21 more elements
A compound, selected from a compound found in the specification and in table 1, or a pharmaceutically acceptable salt, solvate, or stereoisomer thereof.
Dependencies are inferred from the claim text.